Drew Neavin

1.6k citations

19 papers · 744 indexed · h-index 13

Impact in

Biological Psychiatry top 2%
- Tryptophan and brain disorders
Behavioral Neuroscience top 10%
- Stress Responses and Cortisol

Papers in ⓘ

Molecular Biology 8
- Single-cell and spatial transcriptomics 6
- Pluripotent Stem Cells Research 3
Biological Psychiatry 7
- Tryptophan and brain disorders 7

Co-authors: Richard M. Weinshilboum (11 shared papers)Duan Liu (5 shared papers)Balmiki Ray (1 shared paper)Rima Kaddurah‐Daouk (5 shared papers)Mark A. Frye (6 shared papers)Liewei Wang (8 shared papers)William V. Bobo (5 shared papers)A. John Rush (5 shared papers)
Journals: Genome biology (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Drug Metabolism and Disposition (2 papers)iScience (1 paper)Nature Genetics (1 paper)
Partner nations: United States Australia Singapore

In The Last Decade

Drew Neavin

19 papers receiving 738 citations

Peers

Countries citing papers authored by Drew Neavin

Since Specialization

Citations

This map shows the geographic impact of Drew Neavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Neavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Neavin more than expected).

Fields of papers citing papers by Drew Neavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew Neavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Neavin. The network helps show where Drew Neavin may publish in the future.

Co-authors

The 25 scholars most cited alongside Drew Neavin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Drew Neavin Line = papers co-authored together Drew Neavin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases International Journal of Molecular Sciences ·Drew Neavin, Duan Liu, Balmiki Ray, Richard M. Weinshilboum	2018	230
2	TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics Molecular Psychiatry ·M Gupta, Drew Neavin, Duan Liu, Joanna M. Biernacka, Daniel K. Hall‐Flavin, William V. Bobo, Mark A. Frye, Michelle Skime, Gregory D. Jenkins, Anthony Batzler, Krishna R. Kalari, Wayne R. Matson, Swati S. Bhasin, Hongjie Zhu, Taisei Mushiroda, Yusuke Nakamura, Michiaki Kubo, L Wang, Rima Kaddurah‐Daouk, Richard M. Weinshilboum	2016	94
3	Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication Clinical Pharmacology & Therapeutics ·Arjun P. Athreya, Drew Neavin, Tania Carrillo‐Roa, Michelle Skime, Joanna M. Biernacka, Mark A. Frye, A. John Rush, Liewei Wang, Elisabeth B. Binder, Ravishankar K. Iyer, Richard M. Weinshilboum, William V. Bobo	2019	76
4	Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients Translational Psychiatry ·Sudeepa Bhattacharyya, Ahmed T. Ahmed, Matthias Arnold, Duan Liu, Chunqiao Luo, Hongjie Zhu, Siamak MahmoudianDehkordi, Drew Neavin, Gregory Louie, Boadie W. Dunlop, Mark A. Frye, Liewei Wang, Richard M. Weinshilboum, Ranga Krishnan, A. John Rush, Rima Kaddurah‐Daouk	2019	62
5	Single cell eQTL analysis identifies cell type-specific genetic control of gene expression in fibroblasts and reprogrammed induced pluripotent stem cells Genome biology ·Drew Neavin, Quan Nguyen, Maciej Daniszewski, Helena H. Liang, Han Sheng Chiu, Yong Kiat Wee, Anne Senabouth, Samuel W. Lukowski, Duncan E. Crombie, Grace E. Lidgerwood, Damián Hernández, James C. Vickers, Anthony L. Cook, Nathan J. Palpant, Alice Pébay, Alex W. Hewitt, Joseph E. Powell	2021	51
6	Pharmacometabolomics informs pharmacogenomics Metabolomics ·Drew Neavin, Rima Kaddurah‐Daouk, Richard M. Weinshilboum	2016	38
7	Augmentation of Physician Assessments with Multi-Omics Enhances Predictability of Drug Response: A Case Study of Major Depressive Disorder IEEE Computational Intelligence Magazine ·Arjun P. Athreya, Ravishankar K. Iyer, Drew Neavin, Liewei Wang, Richard M. Weinshilboum, Rima Kaddurah‐Daouk, A. John Rush, Mark A. Frye, William V. Bobo	2018	35
8	Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson’s disease Science Advances ·Qian Wang, Minghui Wang, Insup Choi, Lily Sarrafha, M H Liang, Lap Ho, Kurt Farrell, Kristin G. Beaumont, Robert Sebra, Claudia De Sanctis, John F. Crary, Tim Ahfeldt, Joel Blanchard, Drew Neavin, Joseph E. Powell, David A. Davis, Xiaoyan Sun, Bin Zhang, Zhenyu Yue	2024	28
9	Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings Neuropsychopharmacology ·Arjun P. Athreya, Tanja Brückl, Elisabeth B. Binder, A. John Rush, Joanna M. Biernacka, Mark A. Frye, Drew Neavin, Michelle Skime, Ditlev Monrad, Ravishankar K. Iyer, Taryn L. Mayes, Madhukar H. Trivedi, Rickey E. Carter, Liewei Wang, Richard M. Weinshilboum, Paul E. Croarkin, William V. Bobo	2021	22
10	Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19 Drug Metabolism and Disposition ·Sandhya Devarajan, Irene Moon, Ming‐Fen Ho, Nicholas B. Larson, Drew Neavin, Ann M. Moyer, John L. Black, Suzette J. Bielinski, Steven E. Scherer, Liewei Wang, Richard M. Weinshilboum, Joel M. Reid	2019	16
11	Demuxafy: improvement in droplet assignment by integrating multiple single-cell demultiplexing and doublet detection methods Genome biology ·Drew Neavin, Anne Senabouth, Himanshi Arora, Jimmy Tsz Hang Lee, Aida Ripoll-Cladellas, Lude Franke, Shyam Prabhakar, Chun Ye, Davis J. McCarthy, Marta Melé, Martin Hemberg, Joseph E. Powell	2024	14
12	Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder Clinical Pharmacology & Therapeutics ·Sisi Qin, Eugene A. Kiyatkin, Duan Liu, Lingxin Zhang, Drew Neavin, Joanna M. Biernacka, Jia Yu, Richard M. Weinshilboum, Liewei Wang	2019	14
13	Treatment of Major Depressive Disorder in Pediatric Populations SHILAP Revista de lepidopterología ·Drew Neavin, Jeremiah B. Joyce, Cosima Swintak	2018	14
14	Single Nucleotide Polymorphisms at a Distance from Aryl Hydrocarbon Receptor (AHR) Binding Sites Influence AHR Ligand–Dependent Gene Expression Drug Metabolism and Disposition ·Drew Neavin, Jeong‐Heon Lee, Duan Liu, Zhenqing Ye, Hu Li, Liewei Wang, Tamás Ördög, Richard M. Weinshilboum	2019	11
15	Shared genetic susceptibility between trigger finger and carpal tunnel syndrome: a genome-wide association study The Lancet Rheumatology ·Benjamin Patel, Sam O. Kleeman, Drew Neavin, Joseph E. Powell, Georgios Baskozos, Michael Ng, Waheed‐Ul‐Rahman Ahmed, David Bennett, Annina B. Schmid, Dominic Furniss, Akira Wiberg	2022	10
16	Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversity iScience ·Lily Sarrafha, Drew Neavin, Gustavo Morrone Parfitt, Ilya Kruglikov, Kristen Whitney, Ricardo Reyes, Elena Coccia, Tatyana Kareva, Camille Goldman, Regine Tipon, Gist F. Croft, John F. Crary, Joseph E. Powell, Joel Blanchard, Tim Ahfeldt	2023	9
17	Data-driven longitudinal modeling and prediction of symptom dynamics in major depressive disorder: Integrating factor graphs and learning methods Arjun P. Athreya, Subho S. Banerjee, Drew Neavin, Rima Kaddurah‐Daouk, A. John Rush, Mark A. Frye, Liewei Wang, Richard M. Weinshilboum, William V. Bobo, Ravishankar K. Iyer	2017	8
18	Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases Nature Genetics ·Nona Farbehi, Drew Neavin, Anna Cuomo, Lorenz Studer, Daniel G. MacArthur, Joseph E. Powell	2024	6
19	Pitfalls and opportunities for applying latent variables in single-cell eQTL analyses Genome biology ·Angli Xue, Seyhan Yazar, Drew Neavin, Joseph E. Powell	2023	6

About Drew Neavin

Drew Neavin is a scholar working on Molecular Biology, Biological Psychiatry, Pharmacology, Experimental and Cognitive Psychology and Pharmacology, having authored 19 papers that have together received 744 indexed citations. Recurring topics across this work include Tryptophan and brain disorders (7 papers), Single-cell and spatial transcriptomics (6 papers), Treatment of Major Depression (6 papers), Mental Health Research Topics (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Pluripotent Stem Cells Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Biological Psychiatry (178 citations), Behavioral Neuroscience (53 citations), Pharmacology (81 citations), Pharmacology (117 citations) and Health Informatics (9 citations). Drew Neavin has collaborated with scholars based in United States, Australia and Singapore. Frequent co-authors include Richard M. Weinshilboum, Duan Liu, Balmiki Ray, Rima Kaddurah‐Daouk, Mark A. Frye, Liewei Wang, William V. Bobo, A. John Rush, Joanna M. Biernacka and Ravishankar K. Iyer. Their work appears in journals such as Genome biology, Clinical Pharmacology & Therapeutics, Drug Metabolism and Disposition, iScience and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact